Medicare Enrolled

Dr. Marta Bognar, M.D.

Rheumatology · Gainesville, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
700 S ENOTA DR NE, Gainesville, GA 30501
7705313711
Registered in NPPES since 2006
NPI: 1336102425 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bognar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bognar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bognar

Dr. Marta Bognar is a rheumatology specialist in Gainesville, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bognar performed 192,155 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Bognar received a total of $21,516 from 44 pharmaceutical and/or device companies across 1108 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bognar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 4% volume in GA $21,516 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
192,155
Medicare services
Top 4% in GA for rheumatology
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
64,800 $4 $15
Tocilizumab injection (Actemra) 61,361 $5 $11
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
24,798 $11 $50
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
18,031 $33 $90
Rituximab injection, 10 mg
Administration of a 10 mg dose of rituximab medication via injection.
8,513 $63 $175
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
3,671 $25 $110
Infliximab-abda biosimilar injection, 10 mg
This code represents the administration of a 10 mg dose of infliximab-abda, a biosimilar medication. It covers the injection of this specific pharmaceutical product.
1,990 $29 $124
Denosumab injection (Prolia/Xgeva) 1,681 $19 $42
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
804 $87 $250
Sed rate test (inflammation marker)
This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body.
777 $3 $10
C-reactive protein test (inflammation marker)
A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body.
777 $5 $18
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
707 $10 $30
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
699 $8 $25
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
661 $8 $12
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
411 $46 $130
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
382 $11 $35
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
331 $93 $500
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
331 $21 $150
X-ray of hand, 2 views
An X-ray imaging test of the hand using two different angles to visualize the bones and joints.
179 $22 $58
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
150 $6 $30
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
100 $11 $35
Autoimmune disorder antibody test
A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders.
84 $18 $55
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
79 $4 $20
Immunoassay substance analysis, multiple step method
A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material.
66 $11 $30
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
66 $121 $320
Foot X-ray, 3+ views
An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints.
65 $24 $63
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
60 $35 $150
X-ray of lower and sacral spine, 2-3 views
An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area.
52 $15 $40
Knee X-ray, 1-2 views
An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures.
51 $19 $52
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
43 $9 $38
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
42 $29 $95
Tuberculosis blood test (gamma interferon)
A blood test that measures the immune system's response to tuberculosis bacteria using gamma interferon levels.
42 $60 $150
Uric acid level test
A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines.
36 $4 $15
Rheumatoid arthritis antibody test
A blood test to measure antibodies used in assessing rheumatoid arthritis.
36 $13 $45
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
35 $46 $175
Rheumatoid factor level 33 $6 $20
X-ray of upper spine, 2-3 views
An X-ray imaging test of the upper spine using two to three different angles to visualize the bones and structures.
24 $14 $41
Shoulder X-ray, 2+ views
An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures.
24 $14 $34
Cardiac enzyme level (CK-MB) test
A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage.
24 $6 $22
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
23 $13 $32
Complement and antigen measurement
A laboratory test to measure levels of complement proteins and antigens in the blood.
22 $12 $45
Pelvis X-ray, 1-2 views
An X-ray imaging test of the pelvic area using one to two different angles to visualize the bones and joints.
21 $11 $29
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
19 $68 $175
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
19 $29 $30
DNA antibody test (native or double-stranded)
A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body.
12 $13 $50
Measurement of dna antibody, single stranded 12 $12 $45
Quadrivalent influenza vaccine, cell-culture derived
A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics.
11 $33 $57
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
24.6% high complexity
72.6% medium
2.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$21,516
Total received (2018-2024)
Avg $3,074/year across 7 years
Top 15% in GA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
1,108
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,818
2023
$3,680
2022
$3,402
2021
$2,590
2020
$661
2019
$2,495
2018
$4,869

Payments by company (2024)

ABBVIE INC.
$932
Novartis Pharmaceuticals Corporation
$482
Amgen Inc.
$431
Janssen Biotech, Inc.
$406
UCB, Inc.
$222
AstraZeneca Pharmaceuticals LP
$195
GlaxoSmithKline, LLC.
$173
Aurinia Pharma U.S., Inc.
$165
GENZYME CORPORATION
$163
PFIZER INC.
$137
E.R. Squibb & Sons, L.L.C.
$96
Organon Llc
$75
SOBI, INC
$74
Boehringer Ingelheim Pharmaceuticals, Inc.
$64
Radius Health, Inc.
$50
Teva Pharmaceuticals USA, Inc.
$44
Octapharma USA, Inc.
$38
ANI Pharmaceuticals, Inc.
$22
Alexion Pharmaceuticals, Inc.
$20
Kiniksa Pharmaceuticals International, plc
$17
Lilly USA, LLC
$15
Top 3 companies account for 48.3% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$3,968
Novartis Pharmaceuticals Corporation
$2,282
ABBVIE INC.
$1,940
Amgen Inc.
$1,808
AbbVie Inc.
$1,478
PFIZER INC.
$1,415
Janssen Biotech, Inc.
$1,050
E.R. Squibb & Sons, L.L.C.
$1,012
GENZYME CORPORATION
$743
Genentech USA, Inc.
$620
Aurinia Pharma U.S., Inc.
$597
GlaxoSmithKline, LLC.
$588
Horizon Therapeutics plc
$563
Lilly USA, LLC
$552
AstraZeneca Pharmaceuticals LP
$434
AbbVie, Inc.
$420
Boehringer Ingelheim Pharmaceuticals, Inc.
$418
Celgene Corporation
$215
Radius Health, Inc.
$191
SANOFI-AVENTIS U.S. LLC
$155
Horizon Pharma plc
$137
SOBI, INC
$122
Sobi, Inc
$117
Organon Llc
$75
Teva Pharmaceuticals USA, Inc.
$62
Alexion Pharmaceuticals, Inc.
$59
Octapharma USA, Inc.
$54
Fresenius Kabi USA, LLC
$51
Organon LLC
$47
Hikma Pharmaceuticals USA
$38
Gilead Sciences, Inc.
$37
Actelion Pharmaceuticals US, Inc.
$33
Antares Pharma, Inc.
$33
Takeda Pharmaceuticals U.S.A., Inc.
$30
Merck Sharp & Dohme Corporation
$26
Mallinckrodt Enterprises LLC
$23
ANI Pharmaceuticals, Inc.
$22
Kiniksa Pharmaceuticals, Ltd.
$20
Kiniksa Pharmaceuticals International, plc
$17
Regeneron Healthcare Solutions, Inc.
$14
West-Ward Pharmaceuticals
$14
DePuy Synthes Sales Inc.
$12
MEDAC PHARMA, INC.
$12
MEDEXUS PHARMA, INC.
$12
Top 3 companies account for 38.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · Cimzia · DUEXIS · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · Humira · IDACIO · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · Otrexup · PENNSAID · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SOLIRIS · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tavneos · Truxima · Tymlos · UPTRAVI · Uloric · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Gainesville?
Compare rheumatologists in the Gainesville area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
15
County median income
$77,430
Nearest hospital to ZIP centroid (approximate)
NORTHEAST GEORGIA MEDICAL CENTER, INC
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bognar is a mixed practice specialist, with above-average Medicare volume (top 4% in GA), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bognar experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Bognar performed 64,800 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bognar receive payments from pharmaceutical companies?
Yes. Dr. Bognar received a total of $21,516 from 44 companies across 1,108 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bognar's costs compare to other rheumatologists in Gainesville?
Dr. Bognar's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bognar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →